These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29873098)

  • 1. Stakeholders' views and experiences of pharmacist prescribing: a systematic review.
    Jebara T; Cunningham S; MacLure K; Awaisu A; Pallivalapila A; Stewart D
    Br J Clin Pharmacol; 2018 Sep; 84(9):1883-1905. PubMed ID: 29873098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist prescribing: A scoping review about the views and experiences of patients and the public.
    Famiyeh IM; McCarthy L
    Res Social Adm Pharm; 2017; 13(1):1-16. PubMed ID: 26898951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key stakeholders' views on the potential implementation of pharmacist prescribing: A qualitative investigation.
    Jebara T; Cunningham S; MacLure K; Pallivalapila A; Awaisu A; Al Hail M; Stewart D
    Res Social Adm Pharm; 2020 Mar; 16(3):405-414. PubMed ID: 31253499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
    Auta A; Strickland-Hodge B; Maz J
    Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist prescribing: a cross-sectional survey of the views of pharmacists in Nigeria.
    Auta A; Strickland-Hodge B; Maz J; David S
    Int J Pharm Pract; 2018 Apr; 26(2):111-119. PubMed ID: 28497878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review.
    Poh EW; McArthur A; Stephenson M; Roughead EE
    JBI Database System Rev Implement Rep; 2018 Sep; 16(9):1823-1873. PubMed ID: 30204671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholders' views of UK nurse and pharmacist supplementary prescribing.
    Cooper R; Anderson C; Avery T; Bissell P; Guillaume L; Hutchinson A; Lymn J; Murphy E; Ratcliffe J; Ward P
    J Health Serv Res Policy; 2008 Oct; 13(4):215-21. PubMed ID: 18806179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences.
    Zhou M; Desborough J; Parkinson A; Douglas K; McDonald D; Boom K
    Int J Pharm Pract; 2019 Dec; 27(6):479-489. PubMed ID: 31287208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'It's showed me the skills that he has': pharmacists' and mentors' views on pharmacist supplementary prescribing.
    Lloyd F; Parsons C; Hughes CM
    Int J Pharm Pract; 2010 Feb; 18(1):29-36. PubMed ID: 20405593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accessibility of pharmacist prescribing and impacts on medicines access: A systematic review.
    Walpola RL; Issakhany D; Gisev N; Hopkins RE
    Res Social Adm Pharm; 2024 May; 20(5):475-486. PubMed ID: 38326207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation.
    Stewart DC; George J; Bond CM; Diack HL; McCaig DJ; Cunningham S
    Int J Pharm Pract; 2009 Apr; 17(2):89-94. PubMed ID: 20214256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' involvement in and attitudes toward pharmacy practice research: A systematic review of the literature.
    Awaisu A; Alsalimy N
    Res Social Adm Pharm; 2015; 11(6):725-48. PubMed ID: 25698363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of future pharmacists on the potential for development and implementation of pharmacist prescribing in Qatar.
    Diab MI; Ibrahim A; Abdallah O; El-Awaisi A; Zolezzi M; Ageeb RA; Elkhalifa WHI; Awaisu A
    Int J Clin Pharm; 2020 Feb; 42(1):110-123. PubMed ID: 31898166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions of pharmacists' roles in the era of expanding scopes of practice.
    Schindel TJ; Yuksel N; Breault R; Daniels J; Varnhagen S; Hughes CA
    Res Social Adm Pharm; 2017; 13(1):148-161. PubMed ID: 27061142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and evaluation of a team-based pharmacy practice model in a community health system.
    Gill TK; Thornton LM; Schroeder TR; Garrelts JC; Schminke BC; Utz KJ; Gerlach CT
    Am J Health Syst Pharm; 2019 Mar; 76(7):470-477. PubMed ID: 31415682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.
    Hindi AMK; Jacobs S; Schafheutle EI
    Health Soc Care Community; 2019 May; 27(3):565-598. PubMed ID: 30047617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study of UK pharmacy pre-registration graduates' views and reflections on pharmacist prescribing.
    McIntosh T; Stewart D
    Int J Pharm Pract; 2016 Apr; 24(2):139-41. PubMed ID: 26450769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing pharmacist prescribing privileges: Is it time?
    Majercak KR
    J Am Pharm Assoc (2003); 2019; 59(6):783-786. PubMed ID: 31521588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis.
    Kassis A; Moles R; Carter S
    Res Social Adm Pharm; 2024 Aug; 20(8):697-712. PubMed ID: 38685144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.